China, Aug. 25 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study of Mitoxantrone, Cytarabine and Lisaftoclax Combination Therapy for Newly Diagnosed Adult Acute Myeloid Leukemia'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130735
Registration Time: 2026/08/24
Type: Interventional study
Primary Sponsor: The first affiliated hospital of guangzhou university of Chinese medicine
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=336677
Published by HT Digital Content Services with permission from Health Daily Digest....